Albert David Ltd. Share Price Target from 2025 to 2050: Future Outlook
Albert David Limited (ADL), part of the prestigious Kothari Group, has stood as a notable name in India’s pharmaceutical landscape since 1938. With its legacy rooted in innovation and quality, ADL delivers a diverse product range including IV solutions, formulations, herbal dosage forms, bulk drugs, and disposables. In this post, we’ll explore ADL’s share price outlook from 2025 to 2050, covering its core operations, investment appeal, and future growth levers.
Albert David Ltd. Overview: Growth, Products, & Market Presence
Albert David is a Kolkata‑based pharmaceutical manufacturer with WHO‑GMP and USFDA‑compliant facilities in Kolkata, Ghaziabad and Mandideep. The company produces infusion solutions (IV fluids), sterile formulations, herbal medicines, bulk APIs, syringes and needles, supplying domestic and international markets across Asia, Africa, Europe, the Middle East and the Americas. It is especially recognized as one of India’s leading IV fluid manufacturers, both in glass and polyethylene formats.
| Information | |
|---|---|
| Founded | 1938 (Calcutta, India) |
| Sector | Pharmaceuticals |
| Key Segments | IV infusion solutions, pharmaceutical formulations, herbal dosage forms, bulk drugs, disposables |
| Stock Listings | NSE: ALBERTDAVD, BSE: 524075 |
| Market Presence | ~35 countries across Asia, Africa, Middle East, Europe, Americas |
On this page, you will find detailed insights into Albert David Ltd.’s stock, including real-time prices, technical analysis, and long-term forecasts:
✅ Real-Time Stock Price: Updated every minute with the latest market data.
✅ Technical Indicators: Tailored by time frame for accurate trading insights.
✅ Financial Reports: Published quarterly to reflect the company’s performance.
✅ Stock Charts: Refreshed in real time for visual market analysis.
📊 Note: Albert David Ltd.’s stock forecast prices in the tables are automatically updated based on live asset price changes.
Albert David Ltd. Financial Overview & Key Metrics
Albert David Ltd. has demonstrated a consistent and stable performance over recent years. The company’s focus on operational efficiency, prudent cost control, and a growing portfolio of value-added pharmaceutical products has enabled it to maintain healthy margins. Its continued investment in manufacturing infrastructure and brand visibility supports its long-term financial health.
Below is a detailed breakdown of its key financial figures, including revenue, net profit, earnings per share (EPS), and other crucial metrics. These insights enable investors to assess the company’s financial health and long-term growth potential.
Use the landscape mode for best viewing on mobile devices.
Investment Potential & Associated Risks
Why Consider Investing in Albert David Ltd.?
- Established Brand with Legacy: With over eight decades of presence in the Indian pharma sector, Albert David has built deep trust among medical professionals and institutional buyers.
- Diversified Product Portfolio: The company’s wide range of prescription and hospital-use products ensures that it is not overly reliant on a single revenue source, improving business resilience.
- Growing Focus on Wellness & Nutraceuticals: Albert David is expanding into nutraceuticals and wellness products, tapping into India’s growing consumer health awareness and lifestyle-driven demand.
- Strong Domestic Distribution Network: Its extensive distribution channels across India support strong reach in tier-1 and tier-2 cities, aiding consistent revenue generation.
- Backward Integration & Cost Efficiency: With in-house capabilities for select APIs and intermediates, the company maintains a degree of control over input costs and product quality.
Risks to Consider
- Limited International Exposure: Albert David’s revenue is largely domestic; this limits diversification and exposes it to local regulatory and competitive pressures.
- Product Portfolio Concentration: Despite its range, a few key products drive a significant share of its revenue, posing concentration risk.
- Regulatory Compliance Costs: Ongoing compliance with stringent pharma regulations increases operational overhead and requires continual investment in upgrades.
- Modest R&D Investment: Compared to larger pharma peers, Albert David’s R&D spending is limited, potentially impacting innovation and competitiveness over the long term.
- Pricing Controls & Policy Risk: Government-imposed price caps on essential medicines can impact profitability, especially in core product segments.
Albert David Share Price Target: Tomorrow & Weekly Outlook
Albert David stock price forecasts for tomorrow and the upcoming week are based on recent market trends, historical price movements, and key technical indicators. These projections provide valuable insights into potential price changes, enabling traders and investors to make informed decisions.
However, various factors can influence stock prices, including market sentiment, news updates, and global events; therefore, it’s always wise to stay updated and flexible with your strategies.
📊 Below, you will find the expected stock price targets for the coming days:
Error fetching table: cURL error 28: Operation timed out after 5000 milliseconds with 0 bytes received
Technical Analysis of Albert David Ltd. Using Key Indicators
For Albert David Ltd., you can leverage indicator-based technical analysis to identify optimal market entry and exit points. Adjust the time frame according to your trading strategy for more accurate insights.
How to Interpret Technical Analysis Signals:
| ✅ Sell” or “Strong Sell | Indicates bearish (negative) market sentiment, suggesting a potential decline. |
| ✅ Buy” or “Strong Buy | Indicates bullish (positive) market sentiment, signaling a potential uptrend. |
Time Frame Considerations:
- Short-Term Analysis (Intraday/Short Swing Trading): Use time frames ranging from 15 minutes to 2 hours.
- Medium to Long-Term Analysis: If you plan to hold for more than a week, use daily to weekly time frames.
Below, you will find technical indicator-based buy and sell signals based on different time frames to assist in your investment decisions.
Future Growth Drivers for Albert David Ltd.
- Expansion in Nutraceuticals & Wellness Space: The company is enhancing its footprint in the growing OTC and preventive healthcare markets, targeting evolving consumer trends.
- Product Pipeline Diversification: New product launches across pain management, women’s health, and critical care are expected to strengthen its prescription portfolio.
- Manufacturing Capacity Modernization: Upgradation of manufacturing facilities is underway to support higher volumes and regulatory compliance, boosting scalability.
- Partnerships with Healthcare Institutions: Strategic tie-ups with hospitals and diagnostic chains enhance market penetration and brand visibility.
- Entry into Semi-Regulated Markets: Export plans to semi-regulated international markets could provide a new growth avenue while avoiding intense competition from regulated zones.
What Will Drive Albert David’ Share Price Over the Coming Decades?
- Prescription Product Consistency
Continued focus on core therapeutic areas with trusted branded generics supports predictable revenue. - Growth in Preventive Healthcare Demand
Shift toward immunity-boosting, wellness, and OTC nutraceuticals aligns with changing healthcare behaviors. - Strategic Capacity Expansion
Planned expansions in Kolkata and other sites will enable scale benefits and support volume growth. - Digital Engagement with Doctors
Leveraging digital platforms to reach prescribing physicians can improve brand engagement and reduce dependency on field sales teams. - Lean Operational Structure
Cost-conscious operations and internal efficiencies contribute to sustainable profit margins over the long term.
Albert David Share Price Target & Forecast (2025-2050)
This long-term stock price forecast for Albert David Ltd. is based on historical market trends, the company’s growth prospects, and industry analysis. While forecasting stock prices for the long term involves uncertainty, these forecasts help investors gain insight into potential future price movements.
📊 The following table presents the Albert David share price target & forecast from 2025 to 2050, based on current market trends and available data.
Error fetching table: cURL error 28: Operation timed out after 5001 milliseconds with 0 bytes received
The Albert David Ltd. share price targets provided here are for informational purposes only. Both short-term and long-term stock price predictions are based on historical data and market trends, but actual prices may vary due to market fluctuations and external factors. This forecast assumes positive market conditions and does not account for unforeseen risks, economic uncertainties, or company-specific challenges. Investors should conduct their research before making any financial decisions.
Live Stock Chart & Price Trends – Albert David Ltd.
Track Albert David Ltd.’s stock performance in real time with our interactive chart below. This live tool provides up-to-the-minute price movements, trading volume, and market trends, helping investors and market watchers stay fully informed. Easily switch between intraday, daily, weekly, or monthly views, and apply a variety of technical indicators to support deeper analysis. Whether you’re actively trading or simply monitoring the market, this chart offers the insights you need to make smart, timely decisions.
🔗 Also Read: Divi’s Laboratories Share Price Target: Future Outlook
Divi’s Laboratories Ltd. is a globally recognized Indian pharmaceutical company known for manufacturing active pharmaceutical ingredients (APIs), intermediates, and custom synthesis of drug compounds. Read more
Expert Opinions & Market Sentiment
Brokerage & Analyst Ratings
ICICI Direct: Hold – Stable core business but limited aggressive growth drivers compared to peers.
Geojit Financial: Accumulate – Sound fundamentals and expanding product base make it a decent long-term bet.
Sharekhan: Neutral – Needs to demonstrate better innovation and international scaling for a more bullish outlook.
Investor Sentiment & Market Trends
- Institutional Holdings: Relatively modest institutional ownership reflects a cautious but stable interest from long-term investors.
- Retail Investor Participation: The stock has seen increasing traction among retail investors looking for value picks in mid-cap pharma.
- Overall Sentiment: Market outlook remains cautiously optimistic, with expectations pinned on product expansion and operational efficiency.
❓FAQs
Is Albert David Ltd. a good long-term investment?
Yes, its strong legacy, diversified prescription base, and domestic dominance offer stability, especially for conservative investors.
What are Albert David’s main business segments?
The company is focused on formulations, infusion solutions, nutraceuticals, and a few bulk drug intermediates primarily used in hospital care.
Does Albert David Ltd. offer dividends?
Yes, the company has a history of regular dividend payouts, aligning with its shareholder-friendly policies.
Is the company planning any international expansion?
While its primary focus remains domestic, the company has indicated future interest in exporting to semi-regulated overseas markets.
Price Prediction Methodology
Our predictions combine expert analysis, technical indicators, and algorithmic models to provide an informed outlook.
📊 Want to know more? Click here to read our full methodology.
